MRI-based machine learning models predict the malignant biological behavior of meningioma

Author:

Li Maoyuan1,Liu Luzhou2,Qi Jie2,Qiao Ying2,Zeng Hanrui2,Jiang Wen2,Zhu Rui2,Wu Shaoping3

Affiliation:

1. Chengdu Qingbaijiang District People's Hospital

2. The First Affiliated Hospital of Chengdu Medical College

3. Chengdu Medical College

Abstract

Abstract Background The WHO grade and Ki-67 index are independent indices to evaluate the malignant biological behavior of meningioma. This study aims to develop MRI-based machine learning models to predict the malignant biological behavior of meningioma from the perspective of the WHO grade, Ki-67 index, and their combination. Methods This multicenter, retrospective study included 216 meningioma patients (60 male and 156 female), of which 41 were classified as high-grade (WHO II/III) and 175 as low-grade (WHO I). The Ki-67 expression was classified into low-expressed (n=152) and high-expressed (n=64) groups with a threshold of 5%. Among them, there were 83 patients with malignant biological behavior whose WHO grade or Ki-67 index increased either or both. All patients were randomly divided into the training and test sets in a ratio of 7:3. Radiomic features were extracted from the maximum cross-sectional area (2D-ROI) and the whole tumor volume (3D-ROI) of the T1, T2-weighted, and T1 contrast-enhanced sequences, followed by five independent feature selections and eight classifiers. 240 prediction models were constructed for predict WHO grade, Ki-67 and their combination respectively. Models were evaluated by cross-validation in training set (n =151), suitable models were selected by compare the cross-validation area under the curves (AUC) and their relative standard deviations (RSD). Clinical and radiological features were collected and analyzed, and meaningful features were combined with radiomic features to establish the clinical-radiological-radiomic (CRR) models. Receiver operating characteristic (ROC) analysis were used to evaluate those models. Radiomic models and CRR models were compared by Delong test. Results 1218 and 1278 radiomic features were extracted from 2D-ROI and 3D-ROI of each sequence. The selected grade, Ki-67 and their combination radiomic models were T1CE-2D-LASSO-LR, T1CE-3D-LASSO-NB, and T1CE-2D-RFE-LR, with cross-validated AUCs on the training set were 0.878, 0.802, and 0.884, the RSDs were 0.055, 0.048, and 0.051, the test set AUCs were 0.807, 0.792, and 0.840, respectively. Heterogeneous enhancement was associated with high grade and Ki-67 status, while peritumoral edema was associated with high Ki-67 status. The Delong test shows that these significant radiological features did not significantly improve the predictive performance. The AUCs in the test set in predicting grade, Ki-67, and their combination were 0.811, 0.778, and 0.858, respectively. Conclusions This study demonstrated that MRI-based machine learning models could effectively predict the grade, Ki-67 index of meningioma. Models considering these two indices might be valuable for improving the predictive sensitivity and comprehensiveness of prediction of malignant biological behavior of meningiomas.

Publisher

Research Square Platform LLC

Reference30 articles.

1. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary;Louis DN;Neurooncology,2021

2. EANO guideline on the diagnosis and management of meningiomas;Goldbrunner R;Neurooncology,2021

3. Ogasawara C, Philbrick BD, Adamson DC, Meningioma. A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions.Biomedicines. 2021;9(3).

4. Ki-67 protein as a tumour proliferation marker;Menon SS;Clin Chim Acta,2019

5. Resected WHO grade I meningioma and predictors of local control;Nowak-Choi K;J Neurooncol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3